The evolution of Staphylococcus aureus

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
R H Deurenberg, E E Stobberingh

Abstract

A broad variety of infections, ranging from minor infections of the skin to post-operative wound infections can be caused by Staphylococcus aureus. The adaptive power of S. aureus to antibiotics leaded, in the early 1960s, to the emergence of methicillin-resistant S. aureus (MRSA). The cause of resistance to methicillin and all other beta-lactam antibiotics is the mecA gene, which is situated on a mobile genetic element, the staphylococcal cassette chromosome mec (SCCmec). Seven major variants of SCCmec, type I to VII, are distinguished. The most important techniques used to investigate the molecular epidemiology of S. aureus are pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), S. aureus protein A (spa) typing and SCCmec typing (only for MRSA). These techniques have been used to study the evolution of the MRSA clones that have emerged since the early 1960s, and to study their subsequent worldwide dissemination. The early MRSA clones were hospital-associated (HA-MRSA). However, from the late 1990s, community-associated MRSA (CA-MRSA) clones emerged worldwide. CA-MRSA harbors SCCmec type IV, V or VII, the majority belong to other S. aureus lineages compared to HA-MRSA, and CA-MRSA is often associated wi...Continue Reading

References

Apr 1, 1995·Journal of Medical Microbiology·G PrevostY Piemont
Jan 9, 1999·The New England Journal of Medicine·S BlotF Colardyn
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G LinaJ Etienne
Dec 22, 1999·Trends in Microbiology·M C Enright, B G Spratt
Jul 12, 2001·Proceedings of the National Academy of Sciences of the United States of America·J R FitzgeraldJ M Musser
Sep 18, 2001·JAMA : the Journal of the American Medical Association·A V GroomJ E Cheek
Oct 13, 2001·Trends in Microbiology·K HiramatsuT Ito
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roland Leclercq
Feb 2, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·D C OliveiraH de Lencastre
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mark C EnrightBrian G Spratt
Aug 22, 2002·Archives of Microbiology·Brigitte Berger-Bächi, Susanne Rohrer
Nov 1, 2002·Journal of Clinical Microbiology·Keiko OkumaKeiichi Hiramatsu
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cassandra D SalgadoDavid P Calfee
Mar 26, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Teruyo ItoKeiichi Hiramatsu
May 3, 2003·The Journal of Clinical Investigation·Franklin D Lowy
Jul 5, 2003·Journal of Clinical Microbiology·Willem B van LeeuwenAlex van Belkum
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Hilmar WisplinghoffGordon L Archer
Nov 8, 2003·Journal of Clinical Microbiology·O MelterH de Lencastre
Nov 26, 2003·Antimicrobial Agents and Chemotherapy·D Ashley Robinson, Mark C Enright
Dec 11, 2003·JAMA : the Journal of the American Medical Association·Timothy S NaimiRuth Lynfield
Feb 5, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D A Robinson, M C Enright
Feb 6, 2004·Journal of Bacteriology·D Ashley Robinson, Mark C Enright
Feb 10, 2004·Journal of Clinical Microbiology·Marilyn ChungAlexander Tomasz
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Teruyo ItoKeiichi Hiramatsu
Jul 10, 2004·Journal of Clinical Microbiology·F G O'BrienW B Grubb

❮ Previous
Next ❯

Citations

Nov 16, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K Ben SlamaC Torres
Jun 18, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D MithoeA V M Möller
Jul 27, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C-M HoJ-J Lu
Jan 14, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C O BeltrameA M S Figueiredo
Jan 6, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A HorváthM Füzi
Jun 5, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C F M van der DonkE E Stobberingh
Jul 6, 2013·The Lancet Infectious Diseases·Yu-Yu Chuang, Yhu-Chering Huang
Oct 1, 2011·Asian Pacific Journal of Tropical Biomedicine·Rajaretinam Rajesh KannanVincent Samuel Gnana Prakash
Mar 6, 2010·Epidemiology and Infection·S T TokajianG F Araj
Aug 15, 2009·Nature Reviews. Microbiology·Henry F Chambers, Frank R Deleo
Jan 25, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Céline CoelhoPatrícia Poeta
Jul 11, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·F Patrick O'HaraCamilo J Acosta
Feb 14, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tonya CrawfordJoseph S Solomkin
Jul 18, 2009·The Journal of Antimicrobial Chemotherapy·Fred C Tenover, Richard V Goering
Feb 6, 2010·The Journal of Antimicrobial Chemotherapy·Pamela A HunterLaura J V Piddock
Jul 9, 2011·The Journal of Antimicrobial Chemotherapy·Elizabeth MostofskyGili Regev-Yochay
Jan 12, 2011·Antimicrobial Agents and Chemotherapy·Jérôme RobertUNKNOWN ONERBA (Observatoire National de l'Epidémiologie de Résistance Bactérienne aux Antibiotiques)
Dec 21, 2010·Journal of Bacteriology·Eleni TsompanidouEmma L Denham
Sep 4, 2009·Journal of Clinical Microbiology·Liang ChenBarry N Kreiswirth
Aug 16, 2013·BMC Complementary and Alternative Medicine·Jonatas Rafael de OliveiraLuciane Dias de Oliveira
Jun 26, 2009·Annals of Clinical Microbiology and Antimicrobials·Floriana CampanileStefania Stefani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.